These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24912407)

  • 1. Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine.
    Zhang Q; Xiao X; Li M; Li W; Yu M; Zhang H; Ping F; Wang Z; Zheng J
    BMC Complement Altern Med; 2014 Jun; 14():188. PubMed ID: 24912407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlation between intestinal gonadotropin-releasing hormone (GnRH) and proglucagon in hyperlipidemic rats and Goto-Kakizaki (GK) rats.
    Wang L; Wu J; Cao H; Chen R; Zhang N; Fu J; Gao B; Zhang J; Hou R; Tang C; Ji Q
    Endocr Pathol; 2009; 20(4):227-34. PubMed ID: 19669946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota.
    Wang Y; Liu H; Zheng M; Yang Y; Ren H; Kong Y; Wang S; Wang J; Jiang Y; Yang J; Shan C
    Front Endocrinol (Lausanne); 2021; 12():609134. PubMed ID: 34025574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral L-glutamine increases active GLP-1 (7-36) amide secretion and improves glycemic control in stretpozotocin-nicotinamide induced diabetic rats.
    Badole SL; Bagul PP; Mahamuni SP; Khose RD; Joshi AC; Jangam GB; Ghule AE; Raut CG; Khedkar VM; Coutinho EC
    Chem Biol Interact; 2013 Apr; 203(2):530-41. PubMed ID: 23466488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Berberine regulates glycemia
    Wang J; Dai G; Li W
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(5):486-492. PubMed ID: 28087908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Verification of Potential Therapeutic Target Genes in Berberine-Treated Zucker Diabetic Fatty Rats through Bioinformatics Analysis.
    Wu YS; Chen YT; Bao YT; Li ZM; Zhou XJ; He JN; Dai SJ; Li CY
    PLoS One; 2016; 11(11):e0166378. PubMed ID: 27846294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acarbose reduces blood glucose by activating miR-10a-5p and miR-664 in diabetic rats.
    Zhang Q; Xiao X; Li M; Li W; Yu M; Zhang H; Wang Z; Xiang H
    PLoS One; 2013; 8(11):e79697. PubMed ID: 24260283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of sweet taste receptor and gut hormone secretion in modelled type 2 diabetes.
    Feng R; Qian C; Liu Q; Jin Y; Liu L; Li S; Liao Y; Zhou H; Liu W; Rayner CK; Ma J
    Gen Comp Endocrinol; 2017 Oct; 252():142-149. PubMed ID: 28782537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model.
    Patriti A; Facchiano E; Annetti C; Aisa MC; Galli F; Fanelli C; Donini A
    Obes Surg; 2005 Oct; 15(9):1258-64. PubMed ID: 16259883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1.
    Liu Y; Zhou Y; Wang Y; Geng D; Liu J
    Obes Surg; 2011 Sep; 21(9):1424-31. PubMed ID: 21479766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the combination of metformin and fenofibrate on glucose homeostasis in diabetic Goto-Kakizaki rats.
    Oh TJ; Shin JY; Kang GH; Park KS; Cho YM
    Exp Mol Med; 2013 Jul; 45(7):e30. PubMed ID: 23827952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies.
    Yu Y; Liu L; Wang X; Liu X; Liu X; Xie L; Wang G
    Biochem Pharmacol; 2010 Apr; 79(7):1000-6. PubMed ID: 19945441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.
    Xia X; Yan J; Shen Y; Tang K; Yin J; Zhang Y; Yang D; Liang H; Ye J; Weng J
    PLoS One; 2011 Feb; 6(2):e16556. PubMed ID: 21304897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.
    Valverde I; Wang GS; Burghardt K; Kauri LM; Redondo A; Acitores A; Villanueva-Peñacarrillo ML; Courtois P; Sener A; Cancelas J; Malaisse WJ; Scott FW
    Endocrine; 2004 Feb; 23(1):77-84. PubMed ID: 15034199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ileal interposition reduces blood glucose levels and decreases insulin resistance in a type 2 diabetes mellitus animal model by up-regulating glucagon-like peptide-1 and its receptor.
    Sun X; Zheng M; Song M; Bai R; Cheng S; Xing Y; Yuan H; Wang P
    Int J Clin Exp Pathol; 2014; 7(7):4136-42. PubMed ID: 25120793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huang-lian-jie-du-decoction modulates glucagon-like peptide-1 secretion in diabetic rats.
    Yu YL; Lu SS; Yu S; Liu YC; Wang P; Xie L; Wang GJ; Liu XD
    J Ethnopharmacol; 2009 Jul; 124(3):444-9. PubMed ID: 19497359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on glucagon-like peptide-1 secretion by distal ileal administration of nutrients.
    Feng X; Zhong S; Yang J; Wang Y; Liu J
    Obes Surg; 2013 Nov; 23(11):1774-82. PubMed ID: 23873128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes.
    Lang S; Yang J; Yang K; Gu L; Cui X; Wei T; Liu J; Le Y; Wang H; Wei R; Hong T
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32139602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats.
    Lu SS; Yu YL; Zhu HJ; Liu XD; Liu L; Liu YW; Wang P; Xie L; Wang GJ
    J Endocrinol; 2009 Feb; 200(2):159-65. PubMed ID: 18996945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of berberine is mediated by MAPK signaling pathway in experimental diabetic neuropathy in rats.
    Zhou J; Du X; Long M; Zhang Z; Zhou S; Zhou J; Qian G
    Eur J Pharmacol; 2016 Mar; 774():87-94. PubMed ID: 26849937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.